EYLEA 8mg for the treatment of neovascular age-related macular degeneration and diabetic macular edema

---

EP. 1: EYLEA’s unique MoA: What is the rationale for the higher molar dose?

Professor Jean-Francois Korobelnik, University Hospital of Bordeaux, France

January 23rd 2025

---

EP. 2: EYLEA 8mg in focus: Key learnings from the pivotal trials

Professor Varun Chaudhary, McMaster University, Canada

June 5th 2025